Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Taku Asanuma"'
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70:2265-2270
公立学校の職域病院として,過去8年間に15,224例のマンモグラフィ(以下MMG)併用検診を行った.対象は東北6県の教職員であり,50歳代以下が90%以上,49歳以下が約半数を占めた.要精
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69:749-752
乳癌症例に対しLigaSureTM Precise(LSP)を用いて腋窩郭清を行い,電気メスを用いた症例と術後のリンパ漏に関して比較検討した.ドレーン抜去までの平均日数はLSP群(27症例)が5.8日に対
Autor:
Iwao Sasaki, Kenichi Shiiba, Yoshihiro Saitoh, Masayuki Satoh, Taku Asanuma, Ryoichi Anzai, Yukimasa Suzuki, Seiki Matsuno, Takayuki Mizoi
Publikováno v:
The Japanese Journal of Gastroenterological Surgery. 27:2113-2118
大腸癌の血行性転移再発の組織学的予知因子の検索を行った.進行大腸癌の治癒切除症例で, 術後の血行性転移再発症例 (A群) 25例, 非再発症例 (B群) 32例の合計57例を対象とし, 浸潤に伴う,
Autor:
Takayuki Mizoi, Kenichi Shiiba, Yukimasa Suzuki, Yoshihiro Saitoh, Hiroaki Koseki, Ryoichi Anzai, Taku Asanuma, Seiki Matsuno, Kou Miura, Nobuo Ebina, Seiichi Ishii, Takahiko Ohgoshi
Publikováno v:
The journal of the Japanese Practical Surgeon Society. 53:1296-1300
Over the last 18 years, 13 patients with carcinoid tumors of the rectum have been treated at the hospital. Their incidence was at 3.5 percent of rectal cancers. Most patients complained of non-specific anorectal symptoms such as diarrhea or anal blee
Publikováno v:
Surgery today. 27(1)
To clarify the mechanism of immunosuppression in cancer-bearing hosts, the expression of lipocortin-1 (LC1), a new immunosuppressant, and its effects on the in vitro mitogen responsiveness of peripheral blood mononuclear cells (PBMC) were investigate
Autor:
Tetsuyuki Uchiyama, Yu Katayose, Taku Asanuma, Shinichi Egawa, Michiaki Unno, Kenichi Shiiba, Hiromune Shimamura, Michinaga Takahashi, Ryuji Nakamura, Kei Nakagawa, Masaya Oikawa, Kojin Endo, Kuniharu Yamamoto, Shinichi Takemura
Publikováno v:
Journal of Clinical Oncology. 30:e14011-e14011
e14011 Background: Perioperative chemotherapy with FOLFOX4 reduces the progression-free survival of patients with liver metastases from colorectal cancer. However, the benefit of adjuvant treatment after hepatectomy has not been clarified yet. Here,
Autor:
Yoshihiro Saito, Ryoichi Anzai, Yukimasa Suzuki, Hiroaki Koseki, Taku Asanuma, Takahiko Ogoshi, Kenichi Shiiba, Ko Miura, Masayuki Sato, Seiki Matsuno
Publikováno v:
Recent Advances in Management of Digestive Cancers ISBN: 9784431682547
Postoperative intraperitoneal (i.p.) daily administration of recombinant interleukin 2 (rIL-2) was performed in gastric cancer patients with or without peritoneal metastasis. A remarkable increase in NK activity as well as LAK activity in peritoneal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::14bf3dd73bb0bce7ee7c934fd5025d60
https://doi.org/10.1007/978-4-431-68252-3_111
https://doi.org/10.1007/978-4-431-68252-3_111